Abstract
The maintenance of the tissue barrier is essential to protect the host from external pathogens, thus ensuring the survival of the organism. This process requires the integration of various physiological signals originating from the digestive, immune, endocrine, and the nervous system as indicators of overall body fitness. Innate lymphoid cells (ILC) are a group of immune cells equipped for the guarding and maintenance of the tissue barrier against invading pathogens. Extensive research has focused on the regulation of ILC by cytokines derived from immune or non-immune cells, such as the epithelium. However, recent findings suggest that ILC may play an additional role in the monitoring of the overall health status of the host. This requires the combined sensing of cytokines, metabolites, hormones, and neuropeptides. ILC appear to be essential in this process functioning as hubs for the integration of different physiological signals to facilitate barrier immunity. Here, we discuss the emerging literature revealing dietary, metabolic, hormonal, and neuronal signals as important controllers and modulators of ILC function in health and disease.
Similar content being viewed by others
References
Sonnenberg GF, Artis D (2015) Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21:698–708. https://doi.org/10.1038/nm.3892
Eberl G, Colonna M, Di Santo JP, McKenzie ANJ (2015) Innate lymphoid cells: a new paradigm in immunology. Science (80-) 348:aaa6566. https://doi.org/10.1126/science.aaa6566
Liu M, Zhang C (2017) The role of innate lymphoid cells in immune-mediated liver diseases. Front Immunol 8:695. https://doi.org/10.3389/fimmu.2017.00695
Xiong T, Turner J (2018) Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0670-4
Spits H, Artis D, Colonna M, Diefenbach A, di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Vivier E (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 13:145–149. https://doi.org/10.1038/nri3365
Constantinides MG, McDonald BD, Verhoef PA, Bendelac A (2014) A committed precursor to innate lymphoid cells. Nature 508:397–401. https://doi.org/10.1038/nature13047
Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D, Domingues RG, Veiga-Fernandes H, Arnold SJ, Busslinger M, Dunay IR, Tanriver Y, Diefenbach A (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157:340–356. https://doi.org/10.1016/j.cell.2014.03.030
Serafini N, Vosshenrich CAJ, Di Santo JP (2015) Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 15:415–428. https://doi.org/10.1038/nri3855
Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38(4):769–781. https://doi.org/10.1016/j.immuni.2013.02.010
Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjösberg JM, Spits H (2013) Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221–229. https://doi.org/10.1038/ni2534
Zook EC, Kee BL (2016) Development of innate lymphoid cells. Nat Immunol 17:775–782. https://doi.org/10.1038/ni.3481
Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293–301
Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa JI, Ohtani M, Fujii H, Koyasu S (2010) Innate production of TH2 cytokines by adipose tissue-associated c-kit+Sca-1+ lymphoid cells. Nature 463:540–544. https://doi.org/10.1038/nature08636
Price AE, Liang H-E, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci 107:11489–11494. https://doi.org/10.1073/pnas.1003988107
Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062. https://doi.org/10.1038/ni.2104
Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054. https://doi.org/10.1038/ni.2131
Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JKM, Doherty JM, Mills JC, Colonna M (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722–725. https://doi.org/10.1038/nature07537
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371–1375. https://doi.org/10.1038/nature08949
Eder W, Ege MJ, von Mutius E (2006) The asthma epidemic. N Engl J Med 355:2226–2235. https://doi.org/10.1056/NEJMra054308
Maslowski KM, MacKay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol 12:5–9
Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260. https://doi.org/10.1136/bmj.299.6710.1259
Strachan DP (2000) Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 55(Suppl 1):S2–S10. https://doi.org/10.1136/thorax.55.suppl_1.S2
Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75. https://doi.org/10.1038/35095579
Yazdanbakhsh M, Kremsner PG, Van Ree R (2002) Immunology: allergy, parasites, and the hygiene hypothesis. Science (80-.) 296:490–494
Veldhoen M, Brucklacher-Waldert V (2012) Dietary influences on intestinal immunity. Nat Rev Immunol 12:696–708
Wheeler MA, Rothhammer V, Quintana FJ (2017) Control of immune-mediated pathology via the aryl hydrocarbon receptor. J Biol Chem 292:12383–12389
Gu Y-Z, Hogenesch JB, Bradfield CA (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519–561. https://doi.org/10.1146/annurev.pharmtox.40.1.519
Cella M, Colonna M (2015) Aryl hydrocarbon receptor: linking environment to immunity. Semin Immunol 27:310–314
Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ, Bemelman WA, Diefenbach A, Blom B, Spits H (2015) Interleukin-12 and -23 control plasticity of Cd127+ group 1 and group 3 innate lymphoid cells in the intestinal Lamina Propria. Immunity 43:146–160. https://doi.org/10.1016/j.immuni.2015.06.019
Kiss EA, Vonarbourg C, Kopfmann S et al (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science (80-) 334:1561–1565. https://doi.org/10.1126/science.1214914
Qiu J, Heller JJ, Guo X, Chen ZME, Fish K, Fu YX, Zhou L (2012) The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36:92–104. https://doi.org/10.1016/j.immuni.2011.11.011
Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, Wilhelm C, Veldhoen M (2011) Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147:629–640. https://doi.org/10.1016/j.cell.2011.09.025
Lee JS, Cella M, McDonald KG et al (2012) AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of notch. Nat Immunol 13:144–152. https://doi.org/10.1038/ni.2187
Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, Stockinger B (2017) Feedback control of AHR signalling regulates intestinal immunity. Nature 542:242–245. https://doi.org/10.1038/nature21080
Zelante T, Iannitti RG, Cunha C, de Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372–385. https://doi.org/10.1016/j.immuni.2013.08.003
Hall JA, Grainger JR, Spencer SP, Belkaid Y (2011) The role of retinoic acid in tolerance and immunity. Immunity 35:13–22
Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134:921–931
Liu Z-M, Wang K-P, Ma J, Guo Zheng S (2015) The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol 12:553–557. https://doi.org/10.1038/cmi.2014.133
Spencer SP, Wilhelm C, Yang Q et al (2014) Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (80-) 343:432–437. https://doi.org/10.1126/science.1247606
Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, Groom JR, Misiak A, Dungan LS, Sutton CE, Streubel G, Bracken AP, Mills KHG (2013) Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med 210:1117–1124. https://doi.org/10.1084/jem.20121588
Van De Pavert SA, Ferreira M, Domingues RG et al (2014) Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508:123–127. https://doi.org/10.1038/nature13158
Kim MH, Taparowsky EJ, Kim Correspondence CH, Kim CH (2015) Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43:107–119. https://doi.org/10.1016/j.immuni.2015.06.009
Murakami M (2011) Lipid mediators in life science. Exp Anim 60:7–20. https://doi.org/10.1538/expanim.60.7
de Jong AJ, Kloppenburg M, Toes RE, Ioan-Facsinay A (2014) Fatty acids, lipid mediators, and T-cell function. Front Immunol 5:483. https://doi.org/10.3389/fimmu.2014.00483
Theron AJ, Steel HC, Tintinger GR, Gravett CM, Anderson R, Feldman C (2014) Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res 2014:1–16
Cavagnero K, Doherty TA (2017) Cytokine and lipid mediator regulation of group 2 innate lymphoid cells (ILC2s) in human allergic airway disease. J Cytokine Biol 2(2):116. https://doi.org/10.4172/2576-3881.1000116
Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH (2013) Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 132:205–213. https://doi.org/10.1016/j.jaci.2013.03.048
von Moltke J, O’Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM (2017) Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med 214:27–37. https://doi.org/10.1084/jem.20161274
Lund SJ, Portillo A, Cavagnero K, Baum RE, Naji LH, Badrani JH, Mehta A, Croft M, Broide DH, Doherty TA (2017) Leukotriene C4 potentiates IL-33-induced group 2 innate lymphoid cell activation and lung inflammation. J Immunol 199:1096–1104. https://doi.org/10.4049/jimmunol.1601569
Salimi M, Stöger L, Liu W, Go S, Pavord I, Klenerman P, Ogg G, Xue L (2017) Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol 12:556–562. https://doi.org/10.1016/j.jaci.2016.12.958
Ricciotti E, Fitzgerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986–1000. https://doi.org/10.1161/ATVBAHA.110.207449
Boyce JA (2007) Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 217:168–185
Konya V, Mjösberg J (2016) Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett 179:36–42. https://doi.org/10.1016/j.imlet.2016.07.006
Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie ANJ, Spits H, Klenerman P, Ogg G (2014) Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 133:1184–1194.e7. https://doi.org/10.1016/j.jaci.2013.10.056
Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD (2013) Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5:174ra26. https://doi.org/10.1126/scitranslmed.3004812
Tait Wojno ED, Monticelli LA, Tran SV, Alenghat T, Osborne LC, Thome JJ, Willis C, Budelsky A, Farber DL, Artis D (2015) The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol 8:1313–1323. https://doi.org/10.1038/mi.2015.21
Dorris SL, Peebles RS (2012) PGI2 as a regulator of inflammatory diseases. Mediat Inflamm 2012:926968. https://doi.org/10.1155/2012/926968
Zhou W, Toki S, Zhang J, Goleniewksa K, Newcomb DC, Cephus JY, Dulek DE, Bloodworth MH, Stier MT, Polosuhkin V, Gangula RD, Mallal SA, Broide DH, Peebles RS Jr (2016) Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses. Am J Respir Crit Care Med 193:31–42. https://doi.org/10.1164/rccm.201410-1793OC
Harizi H (2013) The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. Biomed Res Int 2013:683405. https://doi.org/10.1155/2013/683405
Smith CL, Dickinson P, Forster T, Craigon M, Ross A, Khondoker MR, France R, Ivens A, Lynn DJ, Orme J, Jackson A, Lacaze P, Flanagan KL, Stenson BJ, Ghazal P (2014) Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nat Commun 5. https://doi.org/10.1038/ncomms5649
Duffin R, OConnor RA, Crittenden S et al (2016) Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science (80-) 351:1333–1338. https://doi.org/10.1126/science.aad9903
Maric J, Ravindran A, Mazzurana L, Björklund ÅK, van Acker A, Rao A, Friberg D, Dahlén SE, Heinemann A, Konya V, Mjösberg J (2017) PGE 2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2017.09.050
Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and Proresolving lipid mediators and pathways. Annu Rev Immunol 25:101–137. https://doi.org/10.1146/annurev.immunol.25.022106.141647
Takabe K, Paugh SW, Milstien S, Spiegel S (2008) “Inside-out” signaling of Sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60:181–195. https://doi.org/10.1124/pr.107.07113
Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, Usher N, Zhu J, Urban JF Jr, Paul WE, Germain RN (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359:114–119. https://doi.org/10.1126/science.aam5809
Talbot S, Foster SL, Woolf CJ (2016) Neuroimmunity: physiology and pathology. Annu Rev Immunol 34:421–447. https://doi.org/10.1146/annurev-immunol-041015-055340
Chiu IM, Von Hehn CA, Woolf CJ (2012) Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 15:1063–1067
Foster SL, Seehus CR, Woolf CJ, Talbot S (2017) Sense and immunity: context-dependent neuro-immune interplay. Front Immunol 8:1463. https://doi.org/10.3389/fimmu.2017.01463
Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar AL, Kabata H, Monticelli LA, Moriyama S, Putzel GG, Rakhilin N, Shen X, Kostenis E, König GM, Senda T, Carpenter D, Farber DL, Artis D (2017) The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature 549:282–286. https://doi.org/10.1038/nature23676
Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour REE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D, Haas BJ, Tickle TL, Trombetta JJ, Baral P, Klose CSN, Mahlakõiv T, Artis D, Rozenblatt-Rosen O, Chiu IM, Levy BD, Kowalczyk MS, Regev A, Kuchroo VK (2017) The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549:351–356. https://doi.org/10.1038/nature24029
Cardoso V, Chesné J, Ribeiro H, García-Cassani B, Carvalho T, Bouchery T, Shah K, Barbosa-Morais NL, Harris N, Veiga-Fernandes H (2017) Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549:277–281. https://doi.org/10.1038/nature23469
Ganea D, Hooper KM, Kong W (2015) The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol (Oxf) 213:442–452. https://doi.org/10.1111/apha.12427
Talbot S, Abdulnour REE, Burkett PR, Lee S, Cronin SJF, Pascal MA, Laedermann C, Foster SL, Tran JV, Lai N, Chiu IM, Ghasemlou N, DiBiase M, Roberson D, von Hehn C, Agac B, Haworth O, Seki H, Penninger JM, Kuchroo VK, Bean BP, Levy BD, Woolf CJ (2015) Silencing nociceptor neurons reduces allergic airway inflammation. Neuron 87:341–355. https://doi.org/10.1016/j.neuron.2015.06.007
Nussbaum JC, Van Dyken SJ, Von Moltke J et al (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502:245–248. https://doi.org/10.1038/nature12526
Moriyama S, Brestoff JR, Flamar A-L et al (2018) β2 −adrenergic receptor–mediated negative regulation of group 2 innate lymphoid cell responses. Science (80-) 359:1056–1061. https://doi.org/10.1126/science.aan4829
Ibiza S, García-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, Misic AM, Bartow-McKenney C, Larson DM, Pavan WJ, Eberl G, Grice EA, Veiga-Fernandes H (2016) Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535:440–443. https://doi.org/10.1038/nature18644
Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309–345. https://doi.org/10.1146/annurev.immunol.18.1.309
Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17:233–247
Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81–151. https://doi.org/10.1210/er.2010-0013
Dunn AJ (2000) Cytokine activation of the HPA Axis. Ann N Y Acad Sci 917:608–617. https://doi.org/10.1111/j.1749-6632.2000.tb05426.x
Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S (2017) Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. J Exp Med 214(12):3531–3541. https://doi.org/10.1084/jem.20171048
Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, Betsuyaku T, Koyasu S, Asano K (2013) Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat Commun 4:2675. https://doi.org/10.1038/ncomms3675
Laffont S, Blanquart E, Guery JC (2017) Sex differences in asthma: a key role of androgen-signaling in group 2 innate lymphoid cells. J Immunol 8:1069. https://doi.org/10.3389/fimmu.2017.01069
Laffont S, Blanquart E, Savignac M, Cénac C, Laverny G, Metzger D, Girard JP, Belz GT, Pelletier L, Seillet C, Guéry JC (2017) Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med 214:1581–1592. https://doi.org/10.1084/jem.20161807
Cephus JY, Stier MT, Fuseini H, Yung JA, Toki S, Bloodworth MH, Zhou W, Goleniewska K, Zhang J, Garon SL, Hamilton RG, Poloshukin VV, Boyd KL, Peebles RS Jr, Newcomb DC (2017) Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation. Cell Rep 21:2487–2499. https://doi.org/10.1016/j.celrep.2017.10.110
Bartemes K, Chen CC, Iijima K, Drake L, Kita H (2018) IL-33-responsive group 2 innate lymphoid cells are regulated by female sex hormones in the uterus. J Immunol 200(1):229–236. https://doi.org/10.4049/jimmunol.1602085
Acknowledgments
This work was supported by the NRW-Return program of the Ministry for Science and Education of North-Rhine-Westphalia and the Deutsche Forschungsgemeinschaft DFG [program grant from the DFG (SPP1937)]. CW is a member of the DFG Excellence Cluster Immunosensation.
Author information
Authors and Affiliations
Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Corresponding author
Additional information
This article is a contribution to the special issue on Innate Lymphoid Cells in Inflammation and Immunity - Guest Editors: Jan-Eric Turner and Georg Gasteiger
Rights and permissions
About this article
Cite this article
Karagiannis, F., Wilhelm, C. Innate lymphoid cells—key immune integrators of overall body homeostasis. Semin Immunopathol 40, 319–330 (2018). https://doi.org/10.1007/s00281-018-0684-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-018-0684-y